HOLD with Calibrated Trim Architecture: 25% at $172, 35% Total Across Full Zone
HOLD is correct because operating inflection is real and durable enough to warrant core exposure, while technical extension is real and the catalyst window is approaching (Q3 earnings early November, Starship Flight 15). Neither fresh Buy at $167.60 nor full Sell at current levels is justified. The probability-weighted expected return at $167.60 is negative on a 1-3 month horizon given overhead supply and FCF burn. The catalyst calendar is the resolution mechanism — let it resolve the debate.
| Position | Action |
|---|---|
| Price push to $172 (primary trigger) | Trim 25% of position |
| Confirmed close above $185 on volume >100M (secondary trigger) | Trim additional 10% of position |
| Full zone execution ($172-$185) | Total trim 35% (residual 65%) |
| New capital at $167.60 | Do NOT initiate; wait for pullback or breakout |
| Pullback to $153-$159 with RSI<50 and constructive basing | Add back 50% of trimmed size at 1.5x normal sizing |
| Confirmed close above $185 on volume >100M | Add remaining 50% at 1x normal sizing |
SpaceX is in the early innings of an operating inflection that will compound for years, with Q2 2026's 92% YoY revenue growth and 93% narrowing of operating losses confirming the J-curve's bend, supported by a fortress balance sheet, a fresh FCC catalyst approving 15,000 next-gen Starlink satellites, and a macro regime structurally tailwinded for aerospace/defense.
| Indicator | Value | Signal |
|---|---|---|
| 50 SMA | $142.27 | bullish |
| 200 SMA | $144.75 | bullish |
| 10 EMA | $159.51 | bullish |
| VWMA | $155.55 | bullish |
| MACD Line | 5.83 | bullish |
| MACD Signal | 4.03 | bullish |
| MACD Histogram | +1.80 | bullish |
| RSI(14) | 64.25 | neutral |
| ATR(14) | $7.07 | neutral |
| Bollinger Upper Band (2σ) | $169.44 | neutral |
| Bollinger Middle Band (20 SMA) | $153.21 |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
EV: $185 (measured move), $193 (June gap fill) · concedes: Starship cadence may slip — Polymarket 'less than 5 launches in 2026' bucket ticked up 8.5pp to 47%, with '5–6 launches' bucket at 54%; Falcon 9 + Falcon Heavy + Starlink + Starshield carry the revenue base regardless; The Polymarket re-rating is a whisper of execution slippage, not a regime change in the operational thesis; Bear's TTM EPS of -$1.10 is technically accurate, though distorted by non-cash derivatives; underlying operating loss narrowed 93% Q1→Q2
SPCX is a SELL at $167.60 due to an 86.7x forward P/E that requires near-perfect execution, a 47% Polymarket-implied Starship execution failure probability, a $16.8B/quarter free cash flow burn that depletes the $100B cash pile in under 6 quarters, and a technical distribution setup with overbought momentum, upper Bollinger Band rejection, and 25.7% overhead supply from the June 2026 crash.
EV: -$148-$153 pullback target (50 SMA/200 SMA/recent swing low) · concedes: Bull is correct that Q2 showed strong revenue growth and margin improvement on a headline basis; Bull is correct that the $100B cash pile provides a buffer (albeit limited); Bull is correct that Falcon 9/Starlink/Starshield provide current cash flow support; Bull is correct that the Polymarket probabilities don't guarantee failure, only assign risk
→ vs conservative: The -16.8 billion dollar free cash flow burn narrative ignores that operating cash flow was positive 2.4 billion in Q2 and that the capital deployment is into validated demand opportunities (Starship, Starlink V2, Starshield) with government and commercial backing
→ vs conservative: The 'cash pile exhausts in six quarters' framing assumes static capex against dynamic revenue—both assumptions Q2 revenue growth of 92 percent year-over-year and operating leverage just demolished
→ vs conservative: Treating Starship execution as the load-bearing thesis is incorrect; Falcon 9 and Starlink at 92 percent revenue growth are the core cash engine, making Starship upside rather than a risk to the thesis
→ vs conservative: Backing off because of 86.7 times forward earnings in a name delivering 90-plus percent growth trajectory is how investors underperform names that actually matter
→ vs neutral: The 25 to 40 percent trim plan at 172 to 185 is selling into the first real test of the new floor, forcing short covering and institutional desks to chase—trimming here harvests only 5 to 10 percent of upside to avoid a drawdown with much smaller probability than the upside scenario warrants
→ vs neutral: Waiting for a 153 to 159 re-entry zone means requiring a 7 to 9 percent pullback in a name up 60 percent off August lows in a confirmed uptrend, which is fighting the tape with low probability of success
→ vs neutral: The 'mirrors June setup that preceded the 49 percent drawdown' argument is textbook chart-pattern confirmation bias; June was a parabolic momentum exhaustion event in a vacuum while current setup has institutional-quality fundamentals with a fresh catalyst that news flow hasn't caught up to
→ vs neutral: The HOLD plan refuses to take an asymmetric bet where wrong about waiting costs 15 to 25 dollars per share in missed upside versus wrong about adding risks only 10 to 12 dollars per share to the 144.75 stop
→ vs conservative: The risk of missing the next leg materially exceeds the risk of a 49 percent repeat drawdown, and current operating fundamentals make that repeat drawdown meaningfully less likely than conservative assumptions suggest
| neutral |
| Bollinger Lower Band (2σ) | $136.99 | neutral |
| Latest Close | $167.60 | neutral |
| %B | 0.92 | neutral |
Support: 136.99 · 142.27 · 144.75 · 153.21 · 159.51 | Resistance: 167.6 · 169.44 · 172.47 · 176.42
SPCX is in a strong intermediate-term uptrend following a sharp mid-summer correction. After bottoming near $104.83 in early August, the stock has rallied approximately +60% to trade at $167.60 on 2026-10-07. The most recent session shows a modest pullback from a fresh recent high ($171.92 on 10-06), suggesting short-term consolidation after a steep 3-day advance. The primary trend is constructive, but price is now stretched versus its short-term moving average and testing the upper Bollinger Band. A measured HOLD stance is warranted, with tactical BUY-on-weakness preferred over chasing the breakout.
Market Cap
$2,209.3B
Share Price (implied)
~$167.66
50-Day Moving Average
$141.25
200-Day Moving Average
$144.46
Forward P/E
86.7x
P/B
17.36x
TTM EPS
-$1.10
Forward EPS
$1.93
Dividend Yield
0%
Debt/Equity
31.21x
Current Ratio
5.12x
FY2023 Revenue
$10,387M
FY2024 Revenue
$14,015M
FY2025 Revenue
$18,674M
Q2 2026 Revenue
$7,814M
Gross Margin (Q2 2026)
55.3%
FY2023 Gross Profit
$4,277M
FY2024 Gross Profit
$6,019M
FY2025 Gross Profit
$9,223M
FY2025 R&D Expense
$8,643M
Q2 2026 R&D
$3,548M
FY2023 Operating Income
$507M
FY2024 Operating Income
$742M
FY2025 Operating Income
($2,064M)
Q2 2026 Operating Income
($141M)
FY2023 Net Income
($4,628M)
FY2024 Net Income
$791M
FY2025 Net Income
($4,937M)
Q1 2026 Net Income
($4,276M)
Q2 2026 Net Income
($541M)
FY2025 Diluted EPS
($0.51)
FY2024 Diluted EPS
$0.002
FY2023 Diluted EPS
($0.44)
FY2023 EBITDA (normalized)
$3,349M
FY2024 EBITDA (normalized)
$5,922M
FY2025 EBITDA (normalized)
$4,952M
FY2023 EBITDA
$3,349M
FY2024 EBITDA
$5,922M
FY2025 EBITDA
$4,952M
Q2 2026 Cash & Equivalents + ST Investments
$100,009M
Q2 2026 Total Debt
$39,708M
Q2 2026 Net Cash Position
~$60.3B
Q2 2026 Net PPE
$66,854M
Q2 2026 Stockholders' Equity
$127,224M
Q2 2026 Total Capitalization
$164,063M
FY2025 Stock-Based Compensation
$1,951M
FY2025 D&A
$6,700M
Deferred Revenue
$14,300M
Q2 2026 Equity Raise
$85,700M
FY2023 Operating Cash Flow
$4,520M
FY2024 Operating Cash Flow
$5,776M
FY2025 Operating Cash Flow
$6,785M
FY2023 Capex
($4,415M)
FY2024 Capex
($11,163M)
FY2025 Capex
($20,906M)
FY2023 Free Cash Flow
$105M
FY2024 Free Cash Flow
($5,387M)
FY2025 Free Cash Flow
($14,121M)
Q2 2026 Free Cash Flow
($16,819M)
FY2025 Debt Issued, net
$8,902M
FY2024 Stock Issued, net
$12,080M
FY2025 Stock Issued, net
$17,682M
Q2 2026 Stock Issued
$85,675M
Q2 2026 Long-Term Debt Issued
$29,118M
Strengths
Concerns
SPCX reported a Q2 2026 operating inflection with 92% YoY revenue growth ($7.8B) and record 55.3% gross margins, while GAAP remains unprofitable (-$1.10 TTM EPS, -$4.9B FY2025 net loss) due to heavy R&D reinvestment ($8.6B FY2025) and non-cash charges. The company's balance sheet was transformed by a historic $85.7B equity raise in Q2 2026, resulting in $100B cash and ~$60B net cash position, effectively eliminating near-term liquidity concerns and funding risk despite deeply negative free cash flow (-$14.1B FY2025). At 86.7x forward P/E, the stock prices in aggressive sustained growth with limited margin for error, supporting a HOLD rating pending confirmation of the operating inflection in Q3 2026.
Macro: Surging 10-year Treasury yield hitting highest level since 2002 with biggest monthly gain since 2022; hawkish Fed chorus insisting inflation remains 'too high'; Polymarket prices 96% probability of zero Fed rate cuts in 2026 and only 6% chance of US recession by year-end; Moody's Zandi and Goldman Sachs warn higher rates already damaging economy and threatening US debt-servicing dynamics; Consumer Discretionary being 'pummeled' by higher rates.